TY - T1 - Patient Preferences for Multiple Myeloma Treatments : A Multinational Qualitative Study SN - / UR - http://hdl.handle.net/10138/334482 T3 - A1 - Janssens, Rosanne; Lang, Tamika; Vallejo, Ana; Galinsky, Jayne; Plate, Ananda; Morgan, Kate; Cabezudo, Elena; Silvennoinen, Raija; Coriu, Daniel; Badelita, Sorina; Irimia, Ruxandra; Anttonen, Minna; Manninen, Riikka-Leena; Schoefs, Elise; Vandebroek, Martina; Vanhellemont, Anneleen; Delforge, Michel; Stevens, Hilde; Simoens, Steven; Huys, Isabelle A2 - PB - Y1 - 2021 LA - eng AB - Background: Investigational and marketed drugs for the treatment of multiple myeloma (MM) are associated with a range of characteristics and uncertainties regarding long term side-effects and efficacy. This raises questions about what matters most to patients living with this disease. This study aimed to understand which characteristics MM patients find most important, and hence should be included as attributes and levels in a subsequent quantitative preference survey among MM patients. Methods:... VO - IS - SP - OP - KW - multiple myeloma; patient preferences; nominal group technique; qualitative research; attributes; drug development; regulatory benefit-risk assessment; health technology assessment; DISCRETE-CHOICE EXPERIMENTS; DATA SATURATION; NOMINAL GROUP; 3122 Cancers N1 - PP - ER -